Přehled o publikaci
2024
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
HLINOMAZ, Ota, Zuzana MOTOVSKA, Petr KALA, Milan HROMADKA, Jan PRECEK et. al.Basic information
Original name
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
Authors
HLINOMAZ, Ota, Zuzana MOTOVSKA, Petr KALA, Milan HROMADKA, Jan PRECEK, Jan MROZEK, Pavel ČERVINKA, Jiri KETTNER, Jan MATEJKA, Ahmad ZOHOOR, Josef BIS and Jiří JARKOVSKÝ
Edition
Hellenic Journal of Cardiology, AMSTERDAM, ELSEVIER, 2024, 1109-9666
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
Netherlands
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
001227067900001
EID Scopus
2-s2.0-85170086758
Keywords in English
Acute myocardial infarction; Cardiogenic shock; Multivessel disease; Culprit vessel primary angioplasty; Multivessel primary angioplasty
Links
LM2023049, research and development project. LX22NPO5104, research and development project. NV19-02-00086, research and development project.
Changed: 22/1/2025 00:50, RNDr. Daniel Jakubík
Abstract
V originále
lt; 0.001). Intra-aortic balloon pump, extracorporeal membrane oxygenation (ECMO), and other mechanical circulatory support systems were more often used in patients with MV-pPCI. Thirty (30)-day and 1-year all-cause mortality rates were similar in the CV-pPCI and MV-pPCI groups (odds ratio, 1.01; 95% confidence interval [CI] 0.77 to 1.32; p = 0.937 and 1.1; 95% CI 0.84 to 1.44; p = 0.477). The presence of 3-vessel disease and the use of ECMO were the strongest adjusted predictors of 30-day and 1-year mortality. Conclusions Our data from an extensive all-comers registry suggests that selective use of MV-pPCI does not increase the all-cause mortality rate in patients with CS-STEMI and MVD compared to CV-pPCI.
